To establish the role of HR genes in estrogen-induced genotoxicity in ovarian cancer cells, we examined DSB formation upon combined treatment of estrogen and BRCA1/BRCA2 ablation in OvCa cell lines from different cancer origins (HO-8910, HO-8910 PM, OVCAR8-8TR and SKOV3), as well as L02 and A549 from non-reproductive tissue. The gene discussed is BRCA1; the disease is ovarian carcinoma.